Straumann Holding AG
SAUHF
Market Cap$20.09B
Close$
Earnings Call Q1 2025
April 30, 2025 - AI Summary
Strong Q1 Performance: Straumann Group reported CHF 681 million in revenue for Q1 2025, reflecting a robust organic growth of 11% year-over-year. This performance was driven by solid demand across all business segments, particularly in the EMEA and APAC regions, despite macroeconomic uncertainties.
Regional Dynamics and Challenges: The EMEA region exhibited exceptional growth due to increasing patient spending, improved reimbursement rates, and market penetration. APAC, particularly outside of China, also showed robust performance. Conversely, North America faced soft demand amid economic challenges, leading to more volatile customer sentiment.
Product Innovation as Growth Driver: Key product launches, such as the new iEXCEL implant system, entry-level SIRIOS intraoral scanner, and the collaboration with SprintRay on chairside 3D printing, are expected to significantly impact growth over the next 12-24 months. The company is focusing on enhancing its digital solutions to improve customer experience and streamline workflows.
Exclusive for Stockcircle Pro members
Sign up
$65.90
50.2% downside
Current Fair Value
50.2% downsideOvervalued by 50.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $20.09 Billion |
|---|---|
| Enterprise Value | $20.24 Billion |
| Dividend Yield | $0.6943 (0.900047370914259%) |
| Earnings per Share | $2.44 |
| Beta | 1.33 |
| Outstanding Shares | 137,947,387 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 43.53 |
|---|---|
| PEG | 364.16 |
| Price to Sales | 3.89 |
| Price to Book Ratio | 9.45 |
| Enterprise Value to Revenue | 4.19 |
| Enterprise Value to EBIT | 21.49 |
| Enterprise Value to Net Income | 31 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.26 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Straumann Holding AG
CEO: Guillaume Daniellot Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Europe, Sales Distributor & Emerging ...